RED BLOOD CELL TRANSFUSION IN PATIENTS WITH PLACENTA ACCRETA SPECTRUM : A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.61841/pcg3wx42Keywords:
Placenta accreta, red blood transfusionAbstract
Background: Placenta accreta spectrum, formerly known as morbidly adherent placenta, refers to the range of pathologic adherence of the placenta, including placenta increta, placenta percreta, and placenta accreta. Maternal morbidity and mortality can occur because of severe and sometimes life-threatening hemorrhage, which often requires blood transfusion.
Methods: By comparing itself to the standards set by the Preferred Reporting Items for Systematic Review and MetaAnalysis (PRISMA) 2020, this study was able to show that it met all of the requirements. So, the experts were able to make sure that the study was as up-to-date as it was possible to be. For this search approach, publications that came out between 2013 and 2023 were taken into account. Several different online reference sources, like Pubmed and SagePub, were used to do this. It was decided not to take into account review pieces, works that had already been published, or works that were only half done.
Result: In the PubMed database, the results of our search brought up 32 articles, whereas the results of our search on SagePub brought up 25 articles. The results of the search conducted for the last year of 2013 yielded a total 32 articles for PubMed and 3 articles for SagePub. In the end, we compiled a total of 3 papers, 2 of which came from PubMed and 1 of which came from SagePub. We included five research that met the criteria.
Conclusion: Based on the studies included in this review, we are unable to recommend the minimum of units of red blood cells that should be available before delivery for patients with placenta accreta spectrum. Future studies in the form of large clinical trials is required to study the minimum of RBCs units for PAS patients before delivery, to better inform future guidelines for predelivery blood ordering and transfusion support.
References
American College of Obstetricians and Gynecologists. Levels of Maternal Care. Obstetric Care Consensus No 2 [Internet]. 2015 [cited 2023 Nov 17];125:502–15. Available from: https://www.acog.org/clinical/clinicalguidance/obstetric-care-consensus/articles/2019/08/levels-of-maternal-care
American College of Obstetricians and Gynecologists; Society for Maternal-Fetal Medicine. Obstetric Care Consensus No. 7: Placenta Accreta Spectrum. Obstet Gynecol [Internet]. 2018 [cited 2023 Nov
;132(6):259–75. Available from: https://pubmed.ncbi.nlm.nih.gov/30461695/
Jauniaux E, Chantraine F, Silver RM, Langhoff-Roos J. FIGO consensus guidelines on placenta accreta spectrum disorders: Epidemiology. Inj J Gynaecol Obstet. 2018;140(3):265–73.
Silver RM, Branch DW. Placenta Accreta Spectrum. N Engl J Med. 2018;378(16):1529–36.
Enste R, Cricchio P, Dewandre PY, Braun T, Leonards CO, Niggemann P, et al. Placenta Accreta Spectrum Part II: hemostatic considerations based on an extended review of the literature. J Perinat Med [Internet]. 2022
[cited 2023 Nov 19]; Available from: https://www.degruyter.com/document/doi/10.1515/jpm-2022-0233/html
Cui R, Li M, Lu J, Bai H, Zhang Z. Management strategies for patients with placenta accreta spectrum disorders who underwent pregnancy termination in the second trimester: a retrospective study. BMC Pregnancy Childbirth [Internet]. 2018 [cited 2023 Nov 19];298. Available from:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042202/
Berek JS, Hacker NF. Berek & Hacker’s gynecologic oncology. 2018. 849 p.
Einerson B, Gilner J, Zuckerwise LC. Placenta Accreta Spectrum. Obstetrics & Gynecology Journal [Internet]. 2023 [cited 2023 Nov 17];142(1):31–50. Available from:
https://journals.lww.com/greenjournal/abstract/2023/07000/placenta_accreta_spectrum.6.aspx
Morlando M, Sarno L, Napolitano R, Capone A, Tessitore G, Maruotti GM, et al. Placenta accreta: incidence and risk factors in an area with a particularly high rate of cesarean section. Acta Obstet Gynecol Scand [Internet]. 2013 [cited 2023 Nov 19];92(4):457–60. Available from:
https://obgyn.onlinelibrary.wiley.com/doi/10.1111/aogs.12080
Schwickert A, van Beekhuizen HJ, Bertholdt C, Fox KA, Kayem G, Morel O, et al. Association of peripartum management and high maternal blood loss at cesarean delivery for placenta accreta spectrum (PAS): A multinational database study. Acta Obstet Gynecol Scand. 2021 Mar 1;100(S1):29–40.
Nieto-Calvache AJ, Palacios-Jaraquemada JM, Osanan G, Cortes-Charry R, Aryananda RA, Bangal VB, et al. Lack of experience is a main cause of maternal death in placenta accreta spectrum patients. Acta Obstet Gynecol Scand. 2021 Aug 1;100(8):1445–53.
Seoud MA, Nasr R, Berjawi GA, Zaatari GS, Seoud TM, Shatila AS, et al. Placenta accreta: Elective versus
emergent delivery as a major predictor of blood loss. J Neonatal Perinatal Med [Internet]. 2017 [cited 2023 Nov 19];10(1):9–15. Available from: https://pubmed.ncbi.nlm.nih.gov/28304318/
Setyawan N, Permana S. Massive transfusion in cesarean section patients with placenta accreta: A case series. Bali Journal of Anesthesiology. 2021;
Munoz JL, Kimura AM, Xenakis E, Jenkins DH, Braverman MA, Ramsey PS, et al. Whole blood transfusion reduces overall component transfusion in cases of placenta accreta spectrum: a pilot program. J Matern Fetal Neonatal Med [Internet]. 2022 [cited 2023 Nov 19];35(25):6455–60. Available from: https://pubmed.ncbi.nlm.nih.gov/33902384/
Thang NM, Anh NTH, Thanh PH, Linh PT, Cuong TD. Emergent versus planned delivery in patients with placenta accreta spectrum disorders. Medicine (Baltimore) [Internet]. 2021 [cited 2023 Nov 19];100(51). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702197/
Bienstock JL, Eke AC, Hueppchen NA. Postpartum Hemorrhage. N Engl J Med [Internet]. 2021 [cited 2023 Nov 19];384(17):1635–45. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10181876/
van Beekhuizen HJ, Stefanovic V, Schwickert A, Henrich W, Fox KA, Gziri MM, et al. A multicenter observational survey of management strategies in 442 pregnancies with suspected placenta accreta spectrum. Acta Obstet Gynecol Scand [Internet]. 2021 [cited 2023 Nov 19];100:12–20. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048500/
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
